Tuhura Biosciences publishes corporate deck on strategies to overcome cancer immunotherapy resistance
Reuters2026/08/12 15:42Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Tuhura Biosciences highlighted a Phase 3 accelerated-approval study of IFx-2.0 in first-line metastatic Merkel cell carcinoma.
- Trial targets about 118 patients, with topline data expected in 2H 2027; design uses ORR primary endpoint, PFS key secondary.
- Program runs under an FDA Special Protocol Assessment; confirmatory trial not expected to be required.
- Tuhura plans to start a Phase 1b/2 trial of VISTA-inhibiting antibody TBS-2025 in mutNPM1 relapsed or refractory AML in 2H 2026.
- Company cited a $50 million credit facility and royalty transaction, projecting operating runway through Q1 2028.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tuhura Biosciences Inc. published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Silver Price Forecast: XAG bullish with eyes on 200-day SMA
FXStreet•2026/08/12 19:24
Pegasus swings to H1 FY26 net loss of EUR 244.69 million; revenue rises 0.6% to EUR 1.51 billion
Reuters•2026/08/12 19:19
Vale, ABB expand AI, automation across Brazil iron ore
Mining.com•2026/08/12 19:18
Crypto prices
MoreBitcoin
BTC
$63,333.73
+0.08%
Ethereum
ETH
$1,882.34
+0.89%
Tether USDt
USDT
$0.9989
-0.02%
USDC
USDC
$0.9998
-0.02%
XRP
XRP
$1.01
-0.28%
Solana
SOL
$75.78
+0.81%
TRON
TRX
$0.3354
+0.20%
Hyperliquid
HYPE
$56.43
+4.42%
Dogecoin
DOGE
$0.07055
-0.13%
Zcash
ZEC
$492.45
+4.19%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now